ARCHIVES

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

DCCP To Have Board Of Scientific Counselors

September 1, 1978

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

July 24, 1992

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979

New Coalition To Lobby for Prevention

November 24, 1978